MBX
MBX Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$28.00
+0.05 ▲ +0.18%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$28.00
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.42 | Insider Own | 40.35% | Shs Outstand | 0.04B | Perf Week | -8.35% |
| Market Cap | 1.33B | Forward P/E | - | EPS next Y | -45.67% | Insider Trans | 4.06% | Shs Float | 0.03B | Perf Month | -20% |
| Enterprise Value | 0.96B | PEG | - | EPS next Q | -0.57 | Inst Own | 70.34% | Short Float | 8.94% | Perf Quarter | -2.85% |
| Income | -0.09B | P/S | - | EPS this Y | -18.94% | Inst Trans | 1.27% | Short Ratio | 3.36 | Perf Half Y | 181.97% |
| Sales | 0.00B | P/B | 3.41 | EPS next 5Y | -21.13% | ROA | -26.61% | Short Interest | 2.40M | Perf YTD | -11.22% |
| Book/sh | 8.22 | P/C | 3.56 | EPS past 3/5Y | -44.91% - | ROE | -27.76% | 52W High | -37.63% ($44.89) | Perf Year | 224.45% |
| Cash/sh | 7.87 | P/FCF | - | Sales past 3/5Y | - | ROIC | -23.53% | 52W Low | 482.5% ($4.81) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -30.43% | Gross Margin | - | Volatility(W/M) | 8.05% 7.73% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.58 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 24.62 | EPS Q/Q | -5.42% | Profit Margin | - | RSI (14) | 34.43 | Recom | 1.45 |
| Dividend Gr. 3/5Y | - | Current Ratio | 24.62 | Sales Q/Q | - | SMA20 | -15.81% ($33.26) | Beta | 1.39 | Target Price | $61.3 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -20.55% ($35.24) | Rel Volume | 1.02 | Prev Close | $27.95 |
| Employees | 63 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 22.16% - | SMA200 | 27.21% ($22.01) | Avg Volume(3M) | 0.71M | Price | $28 |
| IPO | 2024/9/13 | Option/Short | Yes/Yes | Trades | 8546 | Volume | 728,538 | Change | 0.18% |
뉴스 로딩 중...